{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:23:45Z","timestamp":1791563025017,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.020","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:14:38Z","timestamp":1782317678000},"page":"235-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Corneal Epithelial Alterations Associated With Cyclin-Dependent Kinase 4\/6 Inhibitor Therapy in Hormone Receptor\u2013Positive Breast Cancer"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-6983","authenticated-orcid":false,"given":"Esra K\u0131z\u0131ldag","family":"Ozbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Fatih","family":"Ozbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2548-7869","authenticated-orcid":false,"given":"Mehmet Fatih","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Su","family":"Ovali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ajo.2026.06.020_bib0001","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ajo.2026.06.020_bib0002","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as first-line therapy for HR-positive, advanced breast cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N Engl J Med"},{"issue":"32","key":"10.1016\/j.ajo.2026.06.020_bib0003","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","article-title":"MONARCH 3: abemaciclib as initial therapy for advanced breast cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.020_bib0004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","article-title":"Targeting CDK4 and CDK6: from discovery to therapy","volume":"6","author":"Sherr","year":"2016","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.020_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1903765","article-title":"Overall survival with ribociclib plus endocrine therapy in breast cancer","volume":"381","author":"Im","year":"2019","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ajo.2026.06.020_bib0006","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1810527","article-title":"Overall survival with palbociclib and fulvestrant in advanced breast cancer","volume":"379","author":"Turner","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ajo.2026.06.020_bib0007","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/onc.2013.137","article-title":"Signaling through cyclin d-dependent kinases","volume":"33","author":"Choi","year":"2014","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.020_bib0008","first-page":"1442","article-title":"The X, Y, Z hypothesis of corneal epithelial maintenance","volume":"24","author":"Thoft","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.020_bib0009","first-page":"1008","article-title":"Biphasic cell proliferation in transdifferentiation of conjunctival to corneal epithelium in rabbits","volume":"24","author":"Kinoshita","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 19","key":"10.1016\/j.ajo.2026.06.020_bib0010","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1242\/jcs.111.19.2867","article-title":"Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation","volume":"111","author":"Lehrer","year":"1998","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.survophthal.2016.11.008","article-title":"Drug-induced corneal epithelial changes","volume":"62","author":"Raizman","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.020_bib0012","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12886-025-04043-6","article-title":"CDK4\/6 inhibitor-associated vortex keratopathy: a case report","volume":"25","author":"Shu","year":"2025","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0013","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/10781552241301406","article-title":"Bilateral epithelial keratopathy and punctate keratitis due to ribociclib","volume":"31","author":"Bayraktar Bilen","year":"2025","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.020_bib0014","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jfo.2021.11.019","article-title":"Palbociclib as a reversible cause of cornea verticillata","volume":"45","author":"Juarez Acu\u00f1a","year":"2022","journal-title":"J Fr Ophtalmol"},{"issue":"23","key":"10.1016\/j.ajo.2026.06.020_bib0015","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/s41388-019-0695-8","article-title":"Lysosomal trapping of palbociclib and its functional implications","volume":"38","author":"Llanos","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0016","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.jcjo.2019.11.003","article-title":"Ribociclib-associated vortex keratopathy","volume":"55","author":"Saeed","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/20420986241278498","article-title":"Adverse event profiles of CDK4\/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system","volume":"15","author":"Shen","year":"2024","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.020_bib0018","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40360-024-00770-6","article-title":"Comparative analysis of adverse events associated with CDK4\/6 inhibitors based on FDA\u2019s adverse event reporting system: a case control pharmacovigilance study","volume":"25","author":"Lin","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"issue":"17","key":"10.1016\/j.ajo.2026.06.020_bib0019","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","article-title":"Hormone replacement therapy and dry eye syndrome","volume":"286","author":"Schaumberg","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.020_bib0021","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09513590400027257","article-title":"Menopause and dry eye. A possible relationship","volume":"20","author":"Versura","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.020_bib0022","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0023","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.1996.14.3.1018","article-title":"Tamoxifen-associated eye disease: a review","volume":"14","author":"Nayfield","year":"1996","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.020_bib0024","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.020_bib0026","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.020_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000943","article-title":"Drug-induced corneal deposits: an up-to-date review","volume":"7","author":"Sahyoun","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.020_bib0028","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1350-9462(99)00018-X","article-title":"Expression of cyclin-dependent kinase inhibitors during corneal wound repair","volume":"19","author":"Zieske","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.020_bib0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000298751","article-title":"Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics","volume":"224","author":"Guthoff","year":"2010","journal-title":"Ophthalmologica"},{"issue":"22","key":"10.1016\/j.ajo.2026.06.020_bib0030","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1200\/JCO.2005.04.4453","article-title":"Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel","volume":"24","author":"Esmaeli","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.020_bib0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IOP.0000000000000745","article-title":"Evaluation and management of chemotherapy-induced epiphora, punctal and canalicular stenosis, and nasolacrimal duct obstruction","volume":"33","author":"Mansur","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ajo.2026.06.020_bib0032","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICU.0000000000000860","article-title":"Effects of systemic targeted immunosuppressive therapy on ocular surface","volume":"33","author":"Mukhtar","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.020_bib0033","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bjo.2008.150615","article-title":"In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review","volume":"93","author":"Patel","year":"2009","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:31:42Z","timestamp":1788280302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0002939426003296"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.020","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal Epithelial Alterations Associated With Cyclin-Dependent Kinase 4\/6 Inhibitor Therapy in Hormone Receptor\u2013Positive Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}